Literature DB >> 6815692

Brain concentrations of tricyclic antidepressants: single-dose kinetics and relationship to plasma concentrations in chronically dosed rats.

R K Glotzbach, S H Preskorn.   

Abstract

A previously reported method of measuring tricyclic antidepressant concentrations in brain tissue and plasma was used to measure amitriptyline (AMI) in rats following drug administration using different routes, doses, and time intervals. In rats given AMI intraperitoneally (IP), brain concentrations increased during the first 30 min after drug administration and then declined. Brain concentrations increased linearly with changes in IP dosage and increased logarithmically with changes in intravenous dosage. No simple relationship existed between brain and plasma concentrations in acutely dosed rats. However, a linear relationship existed between plasma and brain concentrations in chronically treated animals (r = 0.96, P less than 0.001). The brain:plasma drug ratios observed in chronically treated rats corresponded to ratios reported in man. Thus, conclusions drawn from these studies can probably be extrapolated to the clinical situation. Based on our data, the molar concentration of drug achieved on therapeutic doses is 10(-5)--10(-6) M. This information may aid in understanding the clinical relevance of in vitro drug: receptor binding studies which are typically reported in molar concentrations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6815692     DOI: 10.1007/bf00470582

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  A FATAL CASE OF POISONING WITH AMITRIPTYLINE.

Authors:  I SUNSHINE; J BAEUMLER
Journal:  Nature       Date:  1963-09-14       Impact factor: 49.962

Review 2.  Poisoning by tricyclic antidepressant drugs: general and pharmacokinetic considerations.

Authors:  M H Bickel
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-03

3.  Species differences in the plasma protein binding of desipramine.

Authors:  O Borgå; D L Azarnoff; F Sjöqvist
Journal:  J Pharm Pharmacol       Date:  1968-07       Impact factor: 3.765

4.  Concentrations of amitriptyline and its metabolites in urine, blood and tissue in fatal amitriptyline poisoning.

Authors:  E C Munksgaard
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1969

5.  [Suicide with opipramol (Insidon)].

Authors:  J Angst; H Brandenberger; B Herrmann
Journal:  Psychopharmacologia       Date:  1967

6.  Clinical and biochemical results of a fatal case of desipramine intoxication.

Authors:  M H Bickel; R Brochon; B Friolet; B Herrmann; A R Stofer
Journal:  Psychopharmacologia       Date:  1967

7.  Amitriptyline plasma levels and therapeutic response.

Authors:  V E Ziegler; B T Co; J R Taylor; P J Clayton; J T Biggs
Journal:  Clin Pharmacol Ther       Date:  1976-06       Impact factor: 6.875

8.  Correlation between desipramine levels and (-)-noradrenaline uptake and chronotropic effect in isolated atria of rats.

Authors:  A Babulova; S R Bareggi; A Bonaccorsi; S Garattini; P L Morselli; C Pantarotto
Journal:  Br J Pharmacol       Date:  1973-07       Impact factor: 8.739

9.  Role of the central adrenergic system in mediating amitriptyline-induced alteration in the mammalian blood-brain barrier in vivo.

Authors:  S H Preskorn; B K Hartman; G H Irwin; C W Hughes
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

10.  A liquid chromatographic method for quantitating amitriptyline in brain tissue.

Authors:  S H Preskorn; R K Glotzbach
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more
  31 in total

Review 1.  Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice.

Authors:  M J Burke; S H Preskorn
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

Review 2.  [Therapeutic drug monitoring in epileptology and psychiatry].

Authors:  C Brandt; P Baumann; G Eckermann; C Hiemke; T W May; B Rambeck; B Pohlmann-Eden
Journal:  Nervenarzt       Date:  2008-02       Impact factor: 1.214

3.  Modulatory effects of neuropsychopharmaca on intracellular pH of hippocampal neurones in vitro.

Authors:  Udo Bonnet; Dieter Bingmann; Jens Wiltfang; Norbert Scherbaum; Martin Wiemann
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

4.  Inhibitory potencies of trimipramine and its main metabolites at human monoamine and organic cation transporters.

Authors:  Britta Haenisch; Christoph Hiemke; Heinz Bönisch
Journal:  Psychopharmacology (Berl)       Date:  2011-04-12       Impact factor: 4.530

5.  Frequency-dependent block of field potentials in the rat hippocampal slice caused by tricyclic antidepressants.

Authors:  R Anwyl; M J Rowan
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

6.  Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat.

Authors:  C L DeVane; J W Simpkins; S A Stout
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions.

Authors:  S Unterecker; P Riederer; F Proft; J Maloney; J Deckert; B Pfuhlmann
Journal:  J Neural Transm (Vienna)       Date:  2012-12-20       Impact factor: 3.575

8.  Cerebromicrocirculatory defects in animal model of depression.

Authors:  S H Preskorn; T A Kent; R K Glotzbach; G H Irwin; J V Solnick
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 9.  Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?

Authors:  Christoph Hiemke
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03       Impact factor: 5.270

10.  Ethanol effects on brain concentrations of amitriptyline and the relationship to psychomotor function.

Authors:  S H Preskorn; C W Hughes
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.